The global pharmaceutical analytical testing outsourcing market is forecasted to grow by USD 3562.5 mn during 2025-2030, accelerating at a CAGR of 8.0% during the forecast period. The report on the global pharmaceutical analytical testing outsourcing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing complexity of drug development and innovation, strategic focus on core competencies and operational efficiency, increasing analytical demand for specialized testing capabilities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope |
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 7.4% |
| CAGR | 8% |
| Incremental Value | $3562.5 mn |
Technavio's global pharmaceutical analytical testing outsourcing market is segmented as below:
By Service
- Bioanalytical
- Method development and validation
- Stability testing
- Others
By End-User
- Pharmaceutical companies
- Biopharmaceutical companies
- Biotechnology companies
- Others
By Product Type
- APIs
- Finished products
- Excipients
Geography
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- APAC
- China
- India
- Japan
- South Korea
- Indonesia
- Australia
- South America
- Middle East and Africa
- Rest of World (ROW)
This study identifies the evolution from transactional outsourcing to strategic partnerships as one of the prime reasons driving the global pharmaceutical analytical testing outsourcing market growth during the next few years. Also, increasing adoption of digitalization and laboratory automation and growth of specialized services for advanced therapy medicinal products will lead to sizable demand in the market.
The report on the global pharmaceutical analytical testing outsourcing market covers the following areas:
- Global pharmaceutical analytical testing outsourcing market sizing
- Global pharmaceutical analytical testing outsourcing market forecast
- Global pharmaceutical analytical testing outsourcing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global pharmaceutical analytical testing outsourcing market vendors that include Almac Group Ltd., Cambrex Corp., Catalent Inc., Charles River Laboratories, Dalton Pharma Services, Element Materials Tech., Emery Pharma LLC, Eurofins Scientific SE, Intertek Group Plc, Laboratory Holdings Inc., LGC Ltd., Lucideon Ltd., NAMSA LLC, Nelson Laboratories LLC, Pace Analytical Services LLC, Quotient Sciences Ltd., SGS SA, Source BioScience, Vimta Labs Ltd., WuXi AppTec Co. Ltd.. Also, the global pharmaceutical analytical testing outsourcing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Service
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Pharmaceutical Analytical Testing Outsourcing Market 2020 - 2024
- Historic Market Size - Data Table on Global Pharmaceutical Analytical Testing Outsourcing Market 2020 - 2024 ($ million)
- 5.2 Service segment analysis 2020 - 2024
- Historic Market Size - Service Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Pharmaceutical Analytical Testing Outsourcing Market
- 6.2 Impact of Geopolitical Conflicts on Global Pharmaceutical Analytical Testing Outsourcing Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Service
- 8.1 Market segments
- 8.2 Comparison by Service
- 8.3 Bioanalytical - Market size and forecast 2025-2030
- 8.4 Method development and validation - Market size and forecast 2025-2030
- 8.5 Stability testing - Market size and forecast 2025-2030
- 8.6 Others - Market size and forecast 2025-2030
- 8.7 Market opportunity by Service
- Market opportunity by Service ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Pharmaceutical companies - Market size and forecast 2025-2030
- 9.4 Biopharmaceutical companies - Market size and forecast 2025-2030
- 9.5 Biotechnology companies - Market size and forecast 2025-2030
- 9.6 Others - Market size and forecast 2025-2030
- 9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Product Type
- 10.1 Market segments
- 10.2 Comparison by Product Type
- 10.3 APIs - Market size and forecast 2025-2030
- 10.4 Finished products - Market size and forecast 2025-2030
- 10.5 Excipients - Market size and forecast 2025-2030
- 10.6 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 APAC - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Australia - Market size and forecast 2025-2030
- 12.6 South America - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Argentina - Market size and forecast 2025-2030
- 12.6.3 Chile - Market size and forecast 2025-2030
- 12.7 Middle East and Africa - Market size and forecast 2025-2030
- 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
- 12.7.2 UAE - Market size and forecast 2025-2030
- 12.7.3 Turkey - Market size and forecast 2025-2030
- 12.7.4 Israel - Market size and forecast 2025-2030
- 12.7.5 South Africa - Market size and forecast 2025-2030
- 12.8 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing complexity of drug development and innovation
- Strategic focus on core competencies and operational efficiency
- Increasing analytical demand for specialized testing capabilities
- 13.2 Market challenges
- Maintaining data integrity and security
- Navigating complex and evolving regulatory landscape
- Addressing scarcity of specialized scientific talent
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Evolution from transactional outsourcing to strategic partnerships
- Increasing adoption of digitalization and laboratory automation
- Growth of specialized services for advanced therapy medicinal products
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Almac Group Ltd.
- Almac Group Ltd. - Overview
- Almac Group Ltd. - Product / Service
- Almac Group Ltd. - Key offerings
- SWOT
- 15.5 Cambrex Corp.
- Cambrex Corp. - Overview
- Cambrex Corp. - Product / Service
- Cambrex Corp. - Key offerings
- SWOT
- 15.6 Catalent Inc.
- Catalent Inc. - Overview
- Catalent Inc. - Product / Service
- Catalent Inc. - Key offerings
- SWOT
- 15.7 Charles River Laboratories
- Charles River Laboratories - Overview
- Charles River Laboratories - Business segments
- Charles River Laboratories - Key offerings
- Charles River Laboratories - Segment focus
- SWOT
- 15.8 Dalton Pharma Services
- Dalton Pharma Services - Overview
- Dalton Pharma Services - Product / Service
- Dalton Pharma Services - Key offerings
- SWOT
- 15.9 Element Materials Tech.
- Element Materials Tech. - Overview
- Element Materials Tech. - Product / Service
- Element Materials Tech. - Key offerings
- SWOT
- 15.10 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
- 15.11 Intertek Group Plc
- Intertek Group Plc - Overview
- Intertek Group Plc - Business segments
- Intertek Group Plc - Key offerings
- Intertek Group Plc - Segment focus
- SWOT
- 15.12 Laboratory Holdings Inc.
- Laboratory Holdings Inc. - Overview
- Laboratory Holdings Inc. - Business segments
- Laboratory Holdings Inc. - Key offerings
- Laboratory Holdings Inc. - Segment focus
- SWOT
- 15.13 LGC Ltd.
- LGC Ltd. - Overview
- LGC Ltd. - Product / Service
- LGC Ltd. - Key offerings
- SWOT
- 15.14 NAMSA LLC
- NAMSA LLC - Overview
- NAMSA LLC - Product / Service
- NAMSA LLC - Key offerings
- SWOT
- 15.15 Pace Analytical Services LLC
- Pace Analytical Services LLC - Overview
- Pace Analytical Services LLC - Product / Service
- Pace Analytical Services LLC - Key offerings
- SWOT
- 15.16 SGS SA
- SGS SA - Overview
- SGS SA - Business segments
- SGS SA - Key offerings
- SGS SA - Segment focus
- SWOT
- 15.17 Source BioScience
- Source BioScience - Overview
- Source BioScience - Product / Service
- Source BioScience - Key offerings
- SWOT
- 15.18 WuXi AppTec Co. Ltd.
- WuXi AppTec Co. Ltd. - Overview
- WuXi AppTec Co. Ltd. - Business segments
- WuXi AppTec Co. Ltd. - Key offerings
- WuXi AppTec Co. Ltd. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations